Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: Lapatinib|DRUG: Trastuzumab|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Paclitaxel
Sponsor: GlaxoSmithKline